MIRNA JACOB-PINTRO: Open Payments
NPI 1528027539 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 23 payments from 9 companies in 2025. Trend: 2023 $700 · 2024 $667 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $136 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Amgen Inc. | 4 | $63 |
| PFIZER INC. | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: LEQVIO, REPATHA, LifeVest, VERQUVO, JARDIANCE, ENTRESTO, ELIQUIS, Kerendia.
Industry payments across GA — which companies pay providers there.
